Michael K. Mcfadden, M.D. is an interventional pain medicine pain medicine in Hawkinsville, GA with 29 years of experience. The provider is interventional Pain Medicine is the discipline of medicine devoted to the diagnosis and treatment of pain and related disorders principally with the application of interventional techniques in managing subacute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment. Michael K. Mcfadden, M.D. NPI is 1437156189. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Graduation Year:1995
The provider's business location address is:
202 PERRY HWY STE 101
HAWKINSVILLE, GA
ZIP 31036-748
Phone: (478) 892-7246
Fax: (478) 892-7247
The NPI 1437156189 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Testing for presence of drug (HCPCS:80307)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance (HCPCS:20611)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Injections of lower or sacral spine facet joint using imaging guidance (HCPCS:64493)
- Injections of lower or sacral spine facet joint using imaging guidance (HCPCS:64494)
- Aspiration and/or injection of large joint or joint capsule (HCPCS:20610)
The enumeration date for this NPI number is 7/7/2005 and was last updated on 2/12/2024.